Trial Profile
A Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Of The Efficacy Of Diclectin For Nausea And Vomiting Of Pregnancy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxylamine/pyridoxine (Primary)
- Indications Morning sickness; Nausea and vomiting
- Focus Registrational; Therapeutic Use
- 10 Apr 2019 According to an Alliance Pharma plc media release, Xonvea has been approved in Ireland.
- 10 Apr 2013 Doxylamine/pyridoxine is approved in the US based on the results of this trial according to a Duchesnay media release.
- 16 Sep 2010 Results published in the American Journal of Obstetrics and Gynecology, reported in a Duchesnay Inc. media release.